Exact Sciences Corp. (Nasdaq: EXAS), a leader in advanced cancer diagnostics, today announced that the company plans to release its first quarter 2022 financial results after the close of the U.S. financial markets on April 26, 2022.
Following the release, company management will host a webcast and conference call at 5 p.m. ET to discuss financial results and business progress.
First quarter 2022 webcast & conference call details
|
Date: |
Tuesday, April 26, 2022 |
|
Time: |
5 p.m. ET |
|
Webcast: |
The live webcast can be accessed at www.exactsciences.com |
|
Telephone: |
Domestic callers, dial 888-330-2384 |
|
International callers, dial +1 240-789-2701 |
|
|
Access code for both domestic and international callers: 4437608 |
An archive of the webcast will be available at Exactsciences. A replay of the conference call will be available by calling 800-770-2030 domestically or +1 647-362-9199 internationally.
The access code for the replay of the call is 4437608. The webcast, conference call, and replay are open to all interested parties.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, ExactSciences relentlessly pursues smarter solutions
providing the clarity to take life-changing action, earlier.
Building on the success of Cologuard and Oncotype tests, ExactSciences is investing in its product pipeline to support patients before and throughout their cancer diagnosis and treatment.
ExactSciences unites visionary collaborators to help advance the fight against cancer.
For more information, please visit the company’s website, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook.
Contact:
Megan Jones
Exact Sciences Corp.
meganjones@exactsciences.com
608-535-8815
SOURCE : Exact Sciences Corporation